Palvella Therapeutics (PVLA) Shares Outstanding (Diluted Average) (2020 - 2026)

Palvella Therapeutics (PVLA) has 7 years of Shares Outstanding (Diluted Average) data on file, last reported at $13.1 million in Q1 2026.

• Quarterly Shares Outstanding (Diluted Average) rose 18.81% year-over-year to $13.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.1 million (up 18.81% YoY) and the FY2021 annual result came in at $64.5 million, up 18.48% from the prior year.
• Shares Outstanding (Diluted Average) advanced to $13.1 million in Q1 2026 per PVLA's latest filing, from $11.0 million in the prior quarter.
• Across five years, Shares Outstanding (Diluted Average) topped out at $74.1 million in Q2 2022 and bottomed at $1.1 million in Q2 2023.
• The 5-year median for Shares Outstanding (Diluted Average) is $11.0 million (2025), against an average of $18.3 million.
• The widest annual swing landed in 2023, when Shares Outstanding (Diluted Average) sank 98.52%; it then soared 523.88% in 2025.
• Tracing PVLA's Shares Outstanding (Diluted Average) over 5 years: stood at $74.1 million in 2022, then tumbled by 98.33% to $1.2 million in 2023, then surged by 43.22% to $1.8 million in 2024, then soared by 523.88% to $11.0 million in 2025, then climbed by 18.49% to $13.1 million in 2026.
• Per Business Quant, the three latest PVLA Shares Outstanding (Diluted Average) figures stand at $13.1 million (Q1 2026), $11.0 million (Q3 2025), and $11.0 million (Q2 2025).

Peer Comparison